Myriad Genetics (MYGN) Tops Q4 EPS by 5c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Myriad Genetics (MYGN) PT Raised to $52 at Stephens
August 22, 2018 6:12 AM EDTStephens analyst Drew Jones raised the price target on Myriad Genetics (NASDAQ: MYGN) to $52.00 (from $45.00) while maintaining a Overweight rating.
... MoreMyriad Genetics (MYGN) PT Raised to $38 at Piper Jaffray
August 22, 2018 6:01 AM EDTPiper Jaffray analyst William Quirk raised the price target on Myriad Genetics (NASDAQ: MYGN) to $38.00 (from $32.00) while maintaining a Neutral rating.
... More